Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Nurse's touch boost vein treatment outcomes?

NCT ID NCT07787065

Symptom relief Sponsor: Hospital Universitari Vall d'Hebron Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial tests whether a structured nursing program—including education before the procedure, support during it, and follow-up calls—can improve symptoms and quality of life for people with chronic venous disease undergoing foam sclerotherapy. Participants are randomly assigned to receive usual care or the extra nursing support. The study measures changes in vein severity and quality of life over six months, along with satisfaction with care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A structured nursing intervention program (education, support, and follow-up) added to usual care
What this could lead to
If effective, this program could become a standard part of care to help people recover better and feel more satisfied after vein treatment.
What could go wrong
This is a single-center trial with a modest number of participants, so results may not apply broadly. The extra nursing support may not lead to measurable improvements over usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

79 people

The number who actually took part.

Started

Oct 2020

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with chronic venous insufficiency undergoing ultrasound-guided sclerotherapy, with or without active lower-extremity ulcers. * Patients able to attend all scheduled sessions during the study period. * Patients who provided written informed consent after receiving Exclusion Criteria: * Patients who required hospital admission or discontinued participation during the study period. * Patients who, because of neurological, psychological, or psychiatric conditions, were unable to continue attending the scheduled sessions. Accepts Healthy Volunteers: No Sex: All Gender Based: No Minimum Age: 18 Years Maximum Age: No Limit (N/A)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic venous disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic venous insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic venous disease

Contacts and locations

Locations

  • Hospital Universitari Vall d'Hebron

    Barcelona, 08035, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.